Home › Funds › Robocap Asset Management Ltd › PRCT

Robocap Asset Management Ltd position in PRCT

PROCEPT BIOROBOTICS CORP · Health Care

Robocap Asset Management Ltd reported holding 98,007 shares of PRCT (PROCEPT BIOROBOTICS CORP) in its Q2 2026 13F filing — a position valued at US$2.2M, representing 1.78% of its reported portfolio and ranking #19 among its reported holdings. Robocap Asset Management Ltd has disclosed PRCT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)98.01K sh
Reported value held$2.21M
Portfolio Weight1.78%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Robocap Asset Management Ltd's PRCT position evolved

Robocap Asset Management Ltd first disclosed a stake in PRCT in Q3 2023 at 58,553 shares (US$1.9M). The position peaked in Q4 2024 at 91,071 shares, worth US$7.3M. Across 12 filings, Robocap Asset Management Ltd increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 98,007 shares valued at US$2.2M — a reduction of -2,055 shares quarter over quarter.. Notable position changes include a 67% increase in Q4 2023 (shares rose 18% over the following quarter), a 32% increase in Q3 2025 (shares fell 12% over the following quarter), a 28% trim in Q4 2025 (shares fell 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 58.55K $1.92M New
Q4 2023 97.82K $4.10M Add
Q1 2024 87.15K $4.31M Reduce
Q2 2024 93.58K $5.72M Add
Q3 2024 93.58K $5.72M Hold
Q4 2024 91.07K $7.33M Reduce
Q1 2025 111.00K $6.47M Add
Q2 2025 105.08K $6.05M Reduce
Q3 2025 138.84K $4.96M Add
Q4 2025 99.84K $3.14M Reduce
Q1 2026 100.06K $2.50M Hold
Q2 2026 98.01K $2.21M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PRCT and 13F data

PRCT (PROCEPT BIOROBOTICS CORP) is a Health Care company. 18 other funds we track also report a position in PRCT — the largest reported positions include Soleus Capital Management, L.P. (US$22.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PRCT

All PRCT fund holders →

FAQ

How long has Robocap Asset Management Ltd held PRCT?

Robocap Asset Management Ltd has disclosed PRCT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Robocap Asset Management Ltd's current position in PRCT?

As of Q2 2026, Robocap Asset Management Ltd holds 98.01K shares of PRCT (PROCEPT BIOROBOTICS CORP), valued at $2.21M, representing 1.78% of its reported portfolio and ranking #19.

Has Robocap Asset Management Ltd been buying or selling PRCT?

In the latest 13F filing (Q2 2026), Robocap Asset Management Ltd reduced its position in PRCT. The position peaked in Q4 2024 at 91.07K shares.

Which other funds hold PRCT?

Other major institutional holders of PRCT include Soleus Capital Management, L.P., among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.